KYOTO, Japan, April 26, 2024 /PRNewswire/ -- OMRON Healthcare
Co., Ltd. based in Muko, Kyoto
Prefecture, Japan,
announces to be the official sponsor of May Measurement Month
(MMM,) a global campaign to raise awareness of blood pressure
screening and promote hypertension prevention, detection, and
control. MMM was established by the International Society of
Hypertension in 2017, and since then the Company has participated
in this global campaign. A cumulative total of about 26,000 blood
pressure monitors have been donated to 100 countries and regions,
supporting over 6 million people in total taking their blood
pressures so far. May 17 is set to be
the World Hypertension Day, and there are diverse events organized
by regional societies and committees worldwide. Through this
initiative, the Company supports the measurement of blood pressure
in hypertensive patients and the early detection of atrial
fibrillation, which is considered a life-threatening
arrhythmia.
Logo:
https://kyodonewsprwire.jp/img/202404229813-O1-KVQG0oC5
Blood pressure fluctuates throughout the day in response to a
variety of factors such as temperature, humidity, and physical
factors including stress. Therefore, it is essential to monitor
blood pressure at home in addition to regular health checkups at
medical facilities. A study found that high blood pressure is
estimated to cause more than 10 million deaths worldwide every
year. Another research in Japan
shows that 40% of hypertension patients are unaware of their
symptoms or leave them untreated even if they are aware of the
condition (*1). If hypertension is left untreated, it may cause an
increase in the risk of life-threatening heart/brain diseases such
as stroke and heart failure. On the other hand, early detection and
proper management are well-known to prevent these types of diseases
from progressing. OMRON's goal in participating in this campaign is
to improve the awareness of home blood pressure monitoring and the
early detection of diseases.
In 2024, the MMM campaign stretches from May 1 to July 31 building on the World
Hypertension Day on May 17 and a
global screening campaign will take place for more than 1 million
people over the age of 18. For those who visit the event sites, a
series of professional advice, including nutritious therapy,
lifestyle improvement and blood pressure management, will be
provided and a test to measure the risk level of atrial
fibrillation is available if they wish. Atrial fibrillation is the
most common cause of cardioembolic stroke and can be a source of
cardiogenic brain embolism. Research shows that hypertensive
patients have an incidence of atrial fibrillation three times
higher than normal people (*2). This year, the Company will donate
3,200 sets of upper-arm blood pressure monitors (BPMs), including a
new model with built-in ECG that allows users to record ECG while
monitoring their blood pressure with the aim of supporting the
early detection of atrial fibrillation in hypertension
patients.
The Company has supported home blood pressure measurement
campaigns worldwide to achieve its vision of Going for ZERO (zero
cerebrovascular and cardiovascular diseases). OMRON will continue
to engage in awareness-raising activities for home blood pressure
measurement and ECG recording to support the early detection of
cardiovascular disease risks.
For more information, please visit the following
website: https://maymeasure.org/
Notes:
(*1) The Japanese Society of Hypertension Guidelines for the
Management of Hypertension (JSH 2019)
(*2) Senoo K,Yukawa A, Ohkura T, et al. Screening for untreated
atrial fibrillation in the elderly population: A community-based
study. Pizzi C, ed. PLoS ONE.2022;17(6):e0269506.
View original
content:https://www.prnewswire.co.uk/news-releases/omron-donates-some-3-200-units-of-blood-pressure-monitors-to-global-blood-pressure-screening-campaign-on-world-hypertension-day-302128351.html